147 related articles for article (PubMed ID: 12694334)
1. Immunohistochemical detection of an AGE, a ligand for macrophage receptor, in peritoneum of CAPD patients.
Nakamura S; Tobita K; Tachikawa T; Akamatsu S; Ohno Y; Kan A; Katsuragawa M; Yasumura K; Miyazaki S; Sakai S; Morita T; Hirashawa Y; Niwa T
Kidney Int Suppl; 2003 May; (84):S152-7. PubMed ID: 12694334
[TBL] [Abstract][Full Text] [Related]
2. Role of advanced glycation end products and growth factors in peritoneal dysfunction in CAPD patients.
Nakamura S; Tachikawa T; Tobita K; Miyazaki S; Sakai S; Morita T; Hirasawa Y; Weigle B; Pischetsrieder M; Niwa T
Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S61-7. PubMed ID: 12612955
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD.
Nakayama M; Kawaguchi Y; Yamada K; Hasegawa T; Takazoe K; Katoh N; Hayakawa H; Osaka N; Yamamoto H; Ogawa A; Kubo H; Shigematsu T; Sakai O; Horiuchi S
Kidney Int; 1997 Jan; 51(1):182-6. PubMed ID: 8995732
[TBL] [Abstract][Full Text] [Related]
4. Localization of imidazolone in the peritoneum of capd patients: a factor for a loss of ultrafiltration.
Nakamura S; Miyazaki S; Sakai S; Morita T; Hirasawa Y; Niwa T
Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S107-10. PubMed ID: 11576933
[TBL] [Abstract][Full Text] [Related]
5. Advanced glycation end-products in the peritoneal fluid and in the peritoneal membrane of continuous ambulant peritoneal dialysis patients.
Mahiout A; Ehlerding G; Brunkhorst R
Nephrol Dial Transplant; 1996; 11 Suppl 5():2-6. PubMed ID: 9044298
[TBL] [Abstract][Full Text] [Related]
6. Glycolaldehyde, a reactive intermediate for advanced glycation end products, plays an important role in the generation of an active ligand for the macrophage scavenger receptor.
Nagai R; Matsumoto K; Ling X; Suzuki H; Araki T; Horiuchi S
Diabetes; 2000 Oct; 49(10):1714-23. PubMed ID: 11016456
[TBL] [Abstract][Full Text] [Related]
7. Accumulation of advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultra-filtration.
Honda K; Nitta K; Horita S; Yumura W; Nihei H; Nagai R; Ikeda K; Horiuchi S
Nephrol Dial Transplant; 1999 Jun; 14(6):1541-9. PubMed ID: 10383022
[TBL] [Abstract][Full Text] [Related]
8. Advanced glycation end-products and peritoneal sclerosis.
Nakamura S; Niwa T
Semin Nephrol; 2004 Sep; 24(5):502-5. PubMed ID: 15490420
[TBL] [Abstract][Full Text] [Related]
9. Expression of heat shock proteins 47 and 70 in the peritoneum of patients on continuous ambulatory peritoneal dialysis.
Shioshita K; Miyazaki M; Ozono Y; Abe K; Taura K; Harada T; Koji T; Taguchi T; Kohno S
Kidney Int; 2000 Feb; 57(2):619-31. PubMed ID: 10652040
[TBL] [Abstract][Full Text] [Related]
10. Relationship between malnutrition-inflammation syndrome and ultrafiltration volume in continuous ambulatory peritoneal dialysis patients.
Tinroongroj N; Jittikanont S; Lumlertgul D
J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S94-100. PubMed ID: 22043574
[TBL] [Abstract][Full Text] [Related]
11. Advanced glycation end products stimulate tumor necrosis factor-alpha and interleukin-1 beta secretion by peritoneal macrophages in patients on continuous ambulatory peritoneal dialysis.
Rashid G; Korzets Z; Bernheim J
Isr Med Assoc J; 2006 Jan; 8(1):36-9. PubMed ID: 16450750
[TBL] [Abstract][Full Text] [Related]
12. Ultrafiltration with icodextrins in continuous ambulatory peritoneal dialysis and automated peritoneal dialysis.
Neri L; Viglino G; Cappelletti A; Gandolfo C; Cavalli PL
Adv Perit Dial; 2000; 16():174-6. PubMed ID: 11045287
[TBL] [Abstract][Full Text] [Related]
13. Peritoneal accumulation of AGE and peritoneal membrane permeability.
Park MS; Lee HA; Chu WS; Yang DH; Hwang SD
Perit Dial Int; 2000; 20(4):452-60. PubMed ID: 11007378
[TBL] [Abstract][Full Text] [Related]
14. Exfoliated mesothelial cell and CA-125 in automated peritoneal dialysis (APD) and continuous ambulatory peritoneal dialysis (CAPD) patients.
Kanjanabuch T; Puttipittayathorn N; Leelahavanichkul A; Lieusuwan S; Katavetin P; Mahatanan N; Sriudom K; Chirananthavat T; Thongbor N; Eiam-Ong S
J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S119-25. PubMed ID: 22043578
[TBL] [Abstract][Full Text] [Related]
15. Effects of continuous ambulatory peritoneal dialysis and kidney transplantation on advanced glycation endproducts in the skin and peritoneum.
Shaw S; Akyol M; Bell J; Briggs JD; Dominiczak MH
Cell Mol Biol (Noisy-le-grand); 1998 Nov; 44(7):1061-8. PubMed ID: 9846888
[TBL] [Abstract][Full Text] [Related]
16. Identification of galectin-3 as a high-affinity binding protein for advanced glycation end products (AGE): a new member of the AGE-receptor complex.
Vlassara H; Li YM; Imani F; Wojciechowicz D; Yang Z; Liu FT; Cerami A
Mol Med; 1995 Sep; 1(6):634-46. PubMed ID: 8529130
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical study of human advanced glycosylation end-products (AGE) in chronic renal failure.
Yamada K; Miyahara Y; Hamaguchi K; Nakayama M; Nakano H; Nozaki O; Miura Y; Suzuki S; Tuchida H; Mimura N
Clin Nephrol; 1994 Dec; 42(6):354-61. PubMed ID: 7882598
[TBL] [Abstract][Full Text] [Related]
18. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.
Sezer S; Tutal E; Arat Z; Akçay A; Celik H; Ozdemir FN; Haberal M
J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal evaluation of peritoneal macrophage function and activation during CAPD: maturity, cytokine synthesis and arachidonic acid metabolism.
McGregor SJ; Topley N; Jörres A; Speekenbrink AB; Gordon A; Gahl GM; Junor BJ; Briggs JD; Brock JH
Kidney Int; 1996 Feb; 49(2):525-33. PubMed ID: 8821840
[TBL] [Abstract][Full Text] [Related]
20. Application of monoclonal antibody libraries for the measurement of glycation adducts.
Nagai R; Horiuchi S; Unno Y
Biochem Soc Trans; 2003 Dec; 31(Pt 6):1438-40. PubMed ID: 14641083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
